5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress
The 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress, held in Abu Dhabi on 24 and 25 April 2027, is a regional congress on paediatric haematopoietic stem cell transplantation and gene therapy. This guide covers topic areas consistent with that scope, checks before submitting, what reviewers typically value and how to prepare an abstract before the 31 December 2026 deadline.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Abstract deadline
- 31 December 2026
- Full paper deadline
- Abstracts only, or not stated
- Conference dates
- 24 April 2027 – 25 April 2027
- Details last checked
- 10 November 2026
About the conference
- Conference
- 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress
- Organiser
- Emirates Pediatric Bone Marrow Transplant Congress organising committee
- Venue
- Abu Dhabi, United Arab Emirates
- Scope
- Regional congress on paediatric haematopoietic stem cell transplantation and gene therapy, inviting abstracts until 31 December 2026.
- Submission types
- Abstracts; confirm formats and word limits on the official page
- Website
- Official conference website
Topics consistent with the programme
- Outcomes of paediatric haematopoietic stem cell transplantation for malignant and non-malignant diseases
- Gene therapy approaches for inherited blood and immune disorders in children
- Donor selection, conditioning regimens and graft engineering in paediatric transplantation
- Prevention and management of graft-versus-host disease and transplant infections
- Long-term follow-up, survivorship and quality of life after transplantation
- Transplant services and access to care in the Middle East region
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you submit
- Confirm the work concerns paediatric stem cell transplantation, gene therapy or closely related care.
- Check that the results or experience reported are original and clearly described.
- Describe the patient population, methods and outcomes in sufficient detail.
- Confirm abstract categories and format rules on the official call for abstracts page.
- Submit a complete, co-author-approved abstract before 31 December 2026.
Why This Conference Matters
Haematopoietic stem cell transplantation remains a curative option for many children with malignant and inherited disorders, and gene therapy is creating new possibilities for some of these conditions. Outcomes depend on donor availability, supportive care and long-term follow-up, which vary across regions. A regional congress allows clinicians and researchers to share experience from their own centres, compare practice and discuss how advances in transplantation and gene therapy can be delivered to children in the region.
Who Should Submit
Academic backgrounds
- Paediatric haematology and oncology
- Stem cell transplantation
- Immunology
- Gene and cell therapy
- Paediatric infectious diseases
Institutions and sectors
- Children’s hospitals and transplant centres
- University medical centres
- Cell and gene therapy companies
What Reviewers Typically Value
- Centre-level outcome data that add to evidence on paediatric transplantation in the region.
- Clinical experience with new therapies described clearly enough to inform other teams.
- Studies of complications and supportive care that suggest practical improvements.
- Work addressing access, equity or long-term follow-up for transplanted children.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 31 December 2026. Adjust it to the stage your work has reached.
By 19 Nov 2026
Open the official call for abstracts; confirm the tracks, word limit, format and author rules.
By 3 Dec 2026
Agree the key result, the authors and the presenting author.
By 17 Dec 2026
Draft the structured abstract to the word limit, with results stated as numbers.
By 24 Dec 2026
Circulate to co-authors and an independent reader; revise.
By 29 Dec 2026
Final checks: title, author affiliations, conflicts of interest and track selection.
By 31 Dec 2026
Submit through the official abstract system before the deadline.
What you gain
- Feedback from peers working on the same questions.
- A citable abstract or proceedings paper.
- Contacts for collaboration, employment and future funding.
- A step towards a full journal article.
What happens after you submit
- Acknowledgement: the abstract system confirms receipt; keep the submission number.
- Review: the scientific committee scores abstracts against the track criteria.
- Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
- Registration: presenting authors usually must register by a stated date.
- Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.
What the Organisers Are Looking For
The congress is looking for abstracts on paediatric haematopoietic stem cell transplantation and gene therapy, including clinical outcomes, complications, supportive care and service development. Strong submissions typically report original data or experience with a clear objective and well-described methods. Abstract categories, format requirements and presentation options should be confirmed on the official call for abstracts page of the congress website.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare the abstract, full paper, poster or slides, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 31 December 2026. Dates can change, so confirm them on the official page before you plan your work.
Regional congresses sometimes accept case reports where they offer clear clinical lessons, but this is not guaranteed. Check the accepted abstract types on the official call for abstracts page before preparing a submission.
The official page lists abstract submission; check it for any full paper or proceedings option.
Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.
Sources
- Emirates Pediatric Bone Marrow Transplant Congress organising committee. (2026). 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress. Retrieved 10 November 2026, from https://epbmtc.ae/call-for-abstracts/
How to cite this page
Pubrica Insights. (2026). 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress. Pubrica. https://pubrica.com/insights/calls-and-conferences/5th-emirates-pediatric-bone-marrow-transplant-and-gene-therapy-congres/
Pubrica Insights. “5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/5th-emirates-pediatric-bone-marrow-transplant-and-gene-therapy-congres/.
Pubrica Insights (2026) 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/5th-emirates-pediatric-bone-marrow-transplant-and-gene-therapy-congres/ (Accessed: 10 November 2026).
Pubrica Insights. 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/5th-emirates-pediatric-bone-marrow-transplant-and-gene-therapy-congres/
Conference